The world is hungry for mRNA COVID vaccines like Pfizer's. But we're short of vital components
- Written by Archa Fox, Associate Professor and ARC Future Fellow, The University of Western Australia
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Pfizer’s mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before year’s end.
But Australia isn’t the only...





